590 reports of this reaction
3.4% of all PYRAZINAMIDE reports
#3 most reported adverse reaction
PYREXIA is the #3 most commonly reported adverse reaction for PYRAZINAMIDE, manufactured by ANI Pharmaceuticals, Inc.. There are 590 FDA adverse event reports linking PYRAZINAMIDE to PYREXIA. This represents approximately 3.4% of all 17,268 adverse event reports for this drug.
Patients taking PYRAZINAMIDE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PYREXIA is moderately reported among PYRAZINAMIDE users, representing a notable but not dominant share of adverse events.
In addition to pyrexia, the following adverse reactions have been reported for PYRAZINAMIDE:
The following drugs have also been linked to pyrexia in FDA adverse event reports:
PYREXIA has been reported as an adverse event in 590 FDA reports for PYRAZINAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PYREXIA accounts for approximately 3.4% of all adverse event reports for PYRAZINAMIDE, making it one of the most commonly reported side effect.
If you experience pyrexia while taking PYRAZINAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.